Some new drugs pose risk to vision

Three immune drugs, Yervoy, Opdivo, and Keytruda, may require warning labels if the FDA decides that there are risks to eye health and vision. Currently, the drugs list “uveitis” as a potential adverse effect, but the FDA has found additional complications including retinal detachment and vision loss in their post-marketing reviews of the drugs. A […]